Catherine Blish | |
|---|---|
| Citizenship | United States |
| Education | BS, University of California, Davis, Biochemistry (1993)
PhD, University of Washington, Immunology (1999) MD, University of Washington (2001) Residency: University of Washington Medical Center (2003) American Board of Internal Medicine, Infectious Diseases (2006) |
| Known for | Innate immune system, HIV/AIDS, NK cells |
| Awards | ICAAC Young Investigator Award, American Society for Microbiology (2010)
NIH Director's New Innovator Award, National Institutes of Health (2013) Elected Member, American Society for Clinical Investigation (2016) Fellow, Infectious Diseases Society of America (2017) Chan Zuckerberg Investigator (2017) |
| Scientific career | |
| Fields | Immunology |
| Institutions | Stanford University |
| Website | https://med.stanford.edu/blishlab.html |
Catherine Blish is a translational immunologist and professor at Stanford University. Her lab works on clinical immunology and focuses primarily on the role of the innate immune system in fighting infectious diseases like HIV, dengue fever, and influenza. Her immune cell biology work characterizes the biology and action of Natural Killer (NK) cells and macrophages.[1]
For her previous and ongoing work fighting HIV/AIDS, Blish was awarded the 2018 Avant-Garde Award from the National Institute on Drug Abuse.[2]
- ^ "Catherine Blish: Immunology is on the trail of a killer". Stanford School of Engineering. 2020-04-27. Retrieved 2020-07-12.
- ^ "NIDA's 2018 Avant-Garde awards highlight immune response and killer cells". National Institutes of Health (NIH). 2018-03-13. Retrieved 2020-07-12.